Viral Decay Rates are Similar in HIV-infected Patients with and without TB Coinfection during Treatment with an Efavirenz-based Regimen

Autor:	Augustine Sagoe, J. A. A. Mingle, Awewura Kwara, Hulin Wu, Vincent Boima, Margaret Lartey, Ernest Kenu, Fafa Xexemeku, Hongmei Yang, Kwamena W. Sagoe, Markafui Seshie, Timothy P. Flanigan, Joseph Oliver-Commey
Rok vydání:	2011
Předmět:	Adult Cyclopropanes Male Microbiology (medical) Efavirenz Tuberculosis Anti-HIV Agents Antitubercular Agents HIV Infections chemistry.chemical_compound Acquired immunodeficiency syndrome (AIDS) Antiretroviral Therapy Highly Active Humans Medicine Viremia Reverse-transcriptase inhibitor business.industry HIV virus diseases Viral Load medicine.disease Virology Benzoxazines Regimen Infectious Diseases chemistry Alkynes Coinfection HIV/AIDS Female Viral disease business Viral load medicine.drug
Zdroj:	Clinical Infectious Diseases. 52:547-550
ISSN:	1537-6591 1058-4838
Popis:	Viral decay rates during efavirenz-based therapy were compared between human immunodeficiency virus (HIV)-infected patients without tuberculosis (n = 40) and those with tuberculosis coinfection who were receiving concurrent antituberculous therapy (n = 34). Phase I and II viral decay rates were similar in the 2 groups (P > .05). Overall, concurrent antituberculous therapy did not reduce the efficacy of the HIV treatment.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98507ac31076255d134bfdcbac242806 https://doi.org/10.1093/cid/ciq196 Zobrazit plný text záznamu